Australia markets closed

Jack Nathan Medical Corp. (JNHMF)

OTC Markets OTCQB - OTC Markets OTCQB Delayed price. Currency in USD
Add to watchlist
0.01700.0000 (0.00%)
At close: 04:00PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close0.0000
Open0.0241
Bid0.0212 x 0
Ask0.0358 x 0
Day's range0.0241 - 0.0241
52-week range0.0170 - 0.0610
Volume10,000
Avg. volume225
Market cap2.206M
Beta (5Y monthly)-1.38
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Business Wire

    Jack Nathan Health Signs Letter of Intent

    TORONTO, September 13, 2024--Jack Nathan Medical Corp. (TSXV: "JNH"; OTCQB: "JNHMF") (the "Company") announces that, further to recent Company press releases reporting that the Company will be exploring certain strategic alternatives (see the Company’s August 13, 2024 and August 7, 2024 press releases), the Company has entered into a non-binding letter of intent (the "LOI") for a proposed transaction. The proposed transaction is subject to, among other things, the negotiation and execution of a

  • Business Wire

    Jack Nathan Health® Pursues Strategic Initiatives

    TORONTO, August 13, 2024--Jack Nathan Medical Corp. (TSXV: "JNH"; OTCQB: "JNHMF"), operating as Jack Nathan Health® (the "Company"), one of Canada’s largest healthcare networks, announces that it will evaluate and consider opportunities for strategic options including mergers and acquisitions (M&A). As part of this initiative, a comprehensive data room will be available post-qualification to interested parties. If an agreement for a transaction is signed, further details will be provided by the

  • Business Wire

    Jack Nathan Health Provides Corporate Update

    TORONTO, August 07, 2024--Jack Nathan Medical Corp. (TSXV: "JNH"; OTCQB: "JNHMF") (the "Company") reports that it has entered into today an agreement with its secured lender Wal-Mart Canada Corp. (the "Lender") to provide an additional Cdn$474,000 in debt funding (the "Loan"), which provides additional financing for the Company’s operations for the month of August 2024 while the Company concurrently: (a) pursues alternatives to raise additional financing and explore certain strategic alternative